SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F825B9D31F19D556B9567B4E6E02930ABB74C873D1BF354DB80091E9E8CFC4338710531B90FF20D1898707C7F0E921CC>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F825B9D31F19D556B9567B4E6E02930ABB74C873D1BF354DB80091E9E8CFC4338710531B90FF20D1898707C7F0E921CC
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F825B9D31F19D556B9567B4E6E02930ABB74C873D1BF354DB80091E9E8CFC4338710531B90FF20D1898707C7F0E921CC
http://www.w3.org/2000/01/rdf-schema#comment
"In conclusion the present study supports miR-223 and PAX6 as novel therapeutic targets for glioblastoma."
xsd:string
http://purl.uniprot.org/uniprot/#_9E27A8BBB7EAEF3B0175177AD84222EDE194B8EF9589D0858DD250F4FD6537B513F6494202DBBB7C5136A50CAD0688C5
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F825B9D31F19D556B9567B4E6E02930ABB74C873D1BF354DB80091E9E8CFC4338710531B90FF20D1898707C7F0E921CC
http://purl.uniprot.org/uniprot/Q6VMP0
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F825B9D31F19D556B9567B4E6E02930ABB74C873D1BF354DB80091E9E8CFC4338710531B90FF20D1898707C7F0E921CC
http://purl.uniprot.org/uniprot/#_Q6VMP0-mappedCitation-23970099
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F825B9D31F19D556B9567B4E6E02930ABB74C873D1BF354DB80091E9E8CFC4338710531B90FF20D1898707C7F0E921CC